{"url_path":"/fda/drug/recalls/D-0504-2026","section_key":"summary","section_title":"DRUG Recall: Wells Pharma of Houston LLC — fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag, wells pharma of Houston, NDC 73702-202-03.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-01","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0504-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Wells Pharma of Houston LLC"},"word_count":133,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0504-2026\n\n**Recalling firm:** Wells Pharma of Houston LLC\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-01\n**Report date:** 2026-05-06\n\n## Product\nfentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag, wells pharma of Houston, NDC 73702-202-03.\n\n## Reason\ncGMP deviations.\n\n## Affected lots\n120125202032701, Exp Date 04/01/2026;  122625202032857, Exp Date 04/25/2026;  122625202032862, Exp Date 04/28/2026,  122625202032863. Exp Date 04/28/2026;  122625202032864, Exp Date 04/28/2026;  122625202032865, Exp Date 04/28/2026,  011226202030062, Exp Date 05/14/2026,  011326202030776, Exp Date 05/15/2026;  011326202030077, Exp Date 05/15/2026,  011626202030111, Exp Date 05/20/2026,  011926202030122, Exp Date 05/21/2026;   011926202030123, Exp Date 05/21/2026,  012726202030159, Exp Date 05/28/2026,  020226202030200, Exp Date 06/04/2026,  020326202030216, Exp Date 06/05/2026,  020426202030234, Exp Date 06/06/2026,  02182202030398,   Exp Date 06/20/2026.\n\n## Distribution\nU.S. Nationwide."}